Q: My friend says his uncle is being treated for a disease where he has too much blood and he gets "bloodletting’" every other day, like in the Middle Ages. Is there really such a thing, or is he ...
In the staging of aggressive non-Hodgkin lymphoma (NHL), bone marrow biopsy can be omitted if patients are evaluated with 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG ...
In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones, kidneys, ...
Bone marrow aspiration and biopsy are cornerstone diagnostic procedures within haematology and oncology, routinely employed to assess disorders ranging from haematological malignancies to metabolic ...
Polycythemia vera is not hereditary. While it results from a genetic mutation, or a change in the DNA in a bone marrow cell, the change usually develops during life. It isn’t something you are born ...
Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used. Excess blood cell production in ...
In his final thoughts, Dr Gerds discusses emerging therapies for the treatment of PV. Aaron Gerds, MD, MS: In polycythemia vera [PV], there’s a number of very exciting agents being developed. And it’s ...
Prostate Cancer Observed Survival for Harare, Zimbabwe: Utilizing a Population-Based Cancer Registry Platform We conducted a retrospective study of bone marrow biopsies taken for routine care from ...
Ovarian function suppression in premenopausal patients with concurrent endocrine therapy use. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results